Physiologic changes and dermatoses of pregnancy

International Journal of Dermatology

Volumn 50, Issue 7, 2011, Pages 771-782

  Geraghty, Laurel Naversen ^a   Pomeranz, Miriam Keltz ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; EMOLLIENT AGENT; ETRINATE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

CHOLESTASIS; CLINICAL FEATURE; CONNECTIVE TISSUE; CONNECTIVE TISSUE DISEASE; COUNSELING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ECZEMA; HAIR; HUMAN; INTRAHEPATIC CHOLESTASIS; MUCOSA; NAIL; NEVUS; NOMENCLATURE; PAPULE; PATHOGENESIS; PEMPHIGOID GESTATIONIS; PIGMENTATION; PREGNANCY; PROGNOSIS; PRURIGO; PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PRURITUS; PUSTULAR PSORIASIS; REVIEW; RISK ASSESSMENT; SKIN BIOPSY; SKIN BLOOD VESSEL; SKIN DISEASE;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 79959610389     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04869.x     Document Type: Review

References (69)

1. Wade TR, Wade SL, Jones HE. Skin changes and diseases associated with pregnancy. Obstet Gynecol 1978; 52: 233-242.
2. Wong RC. Physiologic skin changes in pregnancy. Harahap M, Wallach RC, eds. In: Skin Changes and Diseases in Pregnancy. New York: Marcel Dekker, Inc, 1996: 37.
3. Wong RC, Ellis CN. Physiologic skin changes in pregnancy. J Am Acad Dermatol 1984; 10: 929-940.
4. Clark D, Thody AJ, Shuster S, Bowers H. Immunoreactive alpha-MSH in human plasma in pregnancy. Nature 1978; 273: 163-164.
5. Mallick S, Singh SK, Sarkar C, et al. Human placental lipid induces melanogenesis by increasing the expression of tyrosinase and its related proteins in vitro. Pigment Cell Res 2005; 18: 25-33.
6. Esteve E, Saudeau L, Pierre F, et al. [Physiological cutaneous signs in normal pregnancy: a study of 60 pregnant women]. Ann Dermatol Venereol 1994; 121: 227-231.
7. Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol 1998; 37: 429-431.
8. Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol 1992; 31: 375-378.
9. Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6: 977-998.
10. Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698.
11. Barankin B, Silver SG, Carruthers A. The skin in pregnancy. J Cutan Med Surg 2002; 6: 236-240.
12. Pennoyer JW, Grin CM, Driscoll MS, et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol 1997; 36: 378-382.
13. Ellis DL. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome. J Am Acad Dermatol 1991; 25: 467-482.
14. Foucar E, Bentley TJ, Laube DW, Rosai J. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol 1985; 121: 350.
15. Driscoll MS, Grant-Kels JM. Hormones, nevi and melanoma: an approach to the patient. J Am Acad Dermatol 2007; 57: 919-931.
16. Driscoll MS, Grim-Jorgensen CM, Grant Kels JM. Does pregnancy influence the prognosis of malignant melanoma? J Am Acad Dermatol 1993; 29: 619-630.
17. Chang AL, Agredano YZ, Kimball AB. Risk factors associated with striae gravidarum. J Am Acad Dermatol 2004; 51: 881-885.
18. Osman H, Rubeiz N, Tamim H, Nassar AH. Risk factors for the development of striae gravidarum. Am J Obstet Gynecol 2007; 196: 62.
19. Rossi AB, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol 2000; 14: 251-262.
20. Elling SV, Powell FC. Physiologic changes in the skin during pregnancy. Clin Dermatol 1997; 15: 35-43.
21. Cummings K, Derbes VJ. Dermatoses associated with pregnancy. Cutis 1967; 3: 120.
22. Wilkin JK, Smith JG Jr, Cullison DA, et al. Unilateral dermatomal superficial telangiectasia. Nine new cases and a review of unilateral dermatomal superficial telangiectasia. J Am Acad Dermatol 1983; 8: 468-477.
23. Chi CC, Wang SH, Charles-Holmes R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 2009; 160: 1222-1228.
24. Shornick JK. Pregnancy dermatoses. Bolognia JL, Jorizzo JL, Rapini RP, eds. In: Dermatology, 2nd edn. New York: Mosby Elsevier, 2008: 395-402.
25. Katz SI. Herpes gestationis (pemphigoid gestationis). Freedberg I, Eisen AZ, Wolff K, et al., eds. In: Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999: 686.
26. Shornick JK. Dermatoses of pregnancy. Semin Cutan Med Surg 1998; 17: 172-181.
27. Roger D, Vaillant L, Fignon A, et al. Specific pruritic disease of pregnancy: a prospective study of 3192 pregnant women. Arch Dermatol 1994; 130: 734-739.
28. Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 1999; 24: 255-259.
29. Shornick JK, Bangert JL, Freeman RG, et al. Herpes gestationis: clinical and histologic features of 28 cases. J Am Acad Dermatol 1983; 8: 214-224.
30. Jenkins RE, Vaughan Jones SA, Black MM. Conversion of pemphigoid gestationis to bullous pemphigoid - two refractory cases highlighting this association. Br J Dermatol 1995; 135: 595-598.
31. Vaughan Jones SA, Hern S, Nelson-Piercy C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141: 71-81.
32. Aoyama Y, Asai K, Hioki K, et al. Herpes gestationis in a mother and newborn: immunoclinical perspectives based on a weekly follow-up of the enzyme-linked immunoabsorbent assay index of a bullous pemphigoid antigen noncollagenous domain. Arch Dermatol 2007; 143: 1168-1172.
33. Chorzelski TP, Jablonska S, Beutner EH, et al. Herpes gestationis with identical twins in the newborn. Passive transfer of the disease? Arch Dermatol 1976; 112: 1129.
34. Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidence based systematic review. Am J Obstet Gynecol 2003; 188: 1083-1092.
35. Di Zenzo G, Calabresi V, Grosso F, et al. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies. J Invest Dermatol 2007; 127: 864-873.
36. Jenkins RE, Shornick JK, Black BL. Pemphigoid gestationis. J Eur Acad Dermatol Venereol 1993; 2: 163.
37. Sitaru C, Dahnrich C, Probst C, et al. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 2007; 16: 770-777.
38. Beitins IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81: 936-945.
39. Gur C, Diav-Citrin O, Schechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004; 18: 93-101.
40. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-392.
41. Holmes RC. Polymorphic eruption of pregnancy. Semin Dermatol 1989; 8: 18-22.
42. Ahmadi D, Powell FC. Pruritic urticarial papules and plaques of pregnancy: current status. Australas J Dermatol 2005; 46: 53-58.
43. Aronson ID, Bond S, Fiedler VC, et al. Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients. J Am Acad Dermatol 1998; 39: 933-939.
44. Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 2006; 56: 395-404.
45. Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1983; 8: 405.
46. Nurse DS. Prurigo of pregnancy. Australas J Dermatol 1968; 9: 258.
47. Vaughan Jones SA, Black MM. Pregnancy dermatoses. J Am Acad Dermatol 1999; 40: 233.
48. Kroumpouzos G, Cohen LM. Pruritic folliculitis of pregnancy. J Am Acad Dermatol 2000; 43: 132.
49. Zoberman E, Farmer ER. Pruritic folliculitis of pregnancy. Arch Dermatol 1981; 117: 20-22.
50. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-2066.
51. Krompouzos G. Intrahepatic cholestasis of pregnancy: what's new [editorial]. J Eur Acad Dermatol Venereol 2002; 16: 316-318.
52. Ropponen A, Sund R, Riikonen S, et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006; 43: 723-728.
53. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992; 21: 905-921.
54. Paunescu MM, Feier V, Paunescu M, et al. Dermatoses of pregnancy. Acta Dermatovenerol Alp Panonica Adriat 2008; 17: 4-11.
55. Paternoster DM, Fabris F, Palu G, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002; 81: 99-103.
56. Koivurova S, Hartikainen AL, Karinen L, et al. The course of pregnancy and delivery and the use of maternal healthcare services after standard IVF in Northern Finland 1990-1995. Hum Reprod 2002; 17: 2897-2903.
57. Gonzales MC, Reyes H, Arrese M, et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol 1989; 9: 84-90.
58. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94: 189-193.
59. Liefer SA, Stiller RJ, Siddiqui DS, et al. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001; 10: 131-135.
60. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001; 45: 1-19.
61. Chang SE, Kim HH, Choi JH, et al. Impetigo herpetiformis followed by generalized psoriasis: more evidence of same disease entity. Int J Dermatol 2003; 42: 754.
62. Bellman B, Berman B. Skin diseases seriously affecting fetal outcome and maternal health. Harahap K, Wallach RC, eds. In: Skin Changes and Diseases in Pregnancy. New York: Marcell Dekker, Inc., 1996: 129.
63. Green MG, Bragg J, Rosenman KS, Pomeranz MK. Pustular psoriasis of pregnancy in a patient whose dermatosis showed features of acute generalized exanthematous pustulosis. Int J Dermatol 2009; 48: 299-303.
64. Kapoor R, Kapoor JR. Cyclosporin resolves generalized pustular psoriasis of pregnancy. Arch Dermatol 2006; 142: 1373-1375.
65. Oosterling RJ, Nobrega RE, Du Boeuff JA, et al. Impetigo herpetiformis or generalized pustular psoriasis? Arch Dermatol 1978; 114: 1527-1529.
66. Breier-Maly J, Ortel B, Breier F, et al. Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 1999; 198: 61.
67. Charles-Holmes R. Skin diseases specifically associated with pregnancy. Harahap K, Wallach RC, eds. In: Skin Changes and Diseases in Pregnancy. New York: Marcell Dekker, Inc., 1996: 55.
68. Bukhari IA. Impetigo herpetiformis in a primigravida: successful treatment with etretinate. J Drugs Dermatol 2004; 3: 449.
69. Imai N, Watanabe R, Fujiwara H, et al. Successful treatment of impetigo herpetiformis with oral cyclosporine during pregnancy. Arch Dermatol 2002; 138: 128.